Augusta University Health is an academic health center that manages the clinical operations associated with Augusta University. It is a health care network that offers primary, specialty and sub-specialty care in the Augusta, Georgia area and throughout the Southeastern United States.

During the past decade, Augusta University Medical Center conducted 131 clinical trials. In the 10-year time frame, 131 clinical trials started and 92 clinical trials were completed, i.e. on average, 70.2% percent of trials that started reached the finish line to date. In the past 5 years, 52 clinical trials started and 60 clinical trials were completed. i.e. 115.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Augusta University Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 79 trials, followed by "Children's Oncology Group" with 29 trials sponsored, "SWOG Cancer Research Network" with 18 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored and "Gynecologic Oncology Group" with 12 trials sponsored. Other sponsors include 70 different institutions and companies that sponsored additional 49 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Augusta University Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 96 trials as a collaborator, "NRG Oncology" with 28 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "Beat NB Cancer Foundation" with 3 trials as a collaborator. Other collaborators include 79 different institutions and companies that were collaborators in the rest 68 trials.

According to Clinical.Site data, the most researched conditions in "Augusta University Medical Center" are "Cervical Adenocarcinoma" (11 trials), "Recurrent Ovarian Carcinoma" (11 trials), "Cervical Adenosquamous Carcinoma" (10 trials), "Ovarian Endometrioid Adenocarcinoma" (9 trials) and "Recurrent Squamous Cell Lung Carcinoma" (9 trials). Many other conditions were trialed in "Augusta University Medical Center" in a lesser frequency.

Most popular intervention types in "Augusta University Medical Center" are "Drug" (164 trials), "Other" (143 trials), "Biological" (74 trials), "Procedure" (52 trials) and "Radiation" (42 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (85 trials), "Quality-of-Life Assessment" (45 trials), "Questionnaire Administration" (34 trials), "Carboplatin" (29 trials) and "Cyclophosphamide" (28 trials). Other intervention names were less common.

The vast majority of trials in "Augusta University Medical Center" are 163 trials for "All" genders, 58 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Augusta University Medical Center". undefined are not yet recruiting, 45 are recruiting, 89 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 70 completed trials in Augusta University Medical Center, 4 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Augusta University Medical Center, 14 "Phase 1" clinical trials were conducted, 68 "Phase 2" clinical trials and 117 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 16 trials that are defined as “Not Applicable".

Augusta University Medical Center has several departments that took part in Clinical trials: "Children's Hospital of Georgia" - 3 trials, "Augusta Cardiology Clinic, P.C." - 2 trials, "Augusta University Health Pharmacy" - 2 trials